Inspiration Healthcare Group (FRA:LXD1) Net Loan

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:LXD1 Inspiration Healthcare Group PLC FRA:LXD1
50 GF Score
Price €0.24
GF Value €0.24
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Inspiration Healthcare Group Net Loan?

Net Loan only applies to banks and insurance companies.

FRA:LXD1
50GF Score
Inspiration Healthcare Group PLC FRA:LXD1
Net Loan is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Inspiration Healthcare Group (FRA:LXD1) Overvalued in 2026?

Based on GuruFocus' analysis, Inspiration Healthcare Group stock appears to be undervalued. The current stock price of €0.24 is trading 0% below its estimated GF Value™ of €0.24. GuruFocus considers Inspiration Healthcare Group to be Fairly Valued.

Key valuation signals for FRA:LXD1:

  • Net Loan:
  • GF Value™: €0.24 vs. price of €0.24 (0% below fair value)
  • GF Score™: 50/100 with 6 warning signs

No single metric tells the full story. See the FRA:LXD1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Inspiration Healthcare Group Business Description

Other Exchanges IHC:UK
Address Unit 7/8 Commerce Park, Commerce Way, Croydon, GBR, CR0 4YL
Inspiration Healthcare Group PLC supplies outcome-improving medical devices in the areas of neonatal intensive care and patient warming. It operates in the Critical Care Medical Devices segment which includes Critical Care, Operating Theatre, and Home Healthcare. The company derives the maximum of its revenue from the United Kingdom through the Critical Care market division.
50GF Score

Get the complete analysis for FRA:LXD1

Net Loan is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.24
Price
€0.24
GF Value